{"id":"https://openalex.org/A5034725804","orcid":null,"observed_orcids":[],"display_name":"M. Borner","raw_author_names":["M. Borner"],"full_name":"M. Borner","works_count":2,"cited_by_count":1,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5034725804","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I39343248","ror":"https://ror.org/01hcx6992","display_name":"Humboldt-Universit\u00e4t zu Berlin","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},"years":[1996]},{"institution":{"id":"https://openalex.org/I76198965","ror":"https://ror.org/05qpz1x62","display_name":"Friedrich Schiller University Jena","country_code":"DE","type":"education","lineage":["https://openalex.org/I76198965"]},"years":[1996]},{"institution":{"id":"https://openalex.org/I7877124","ror":"https://ror.org/001w7jn25","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]},"years":[1996]}],"last_known_institutions":[{"id":"https://openalex.org/I39343248","ror":"https://ror.org/01hcx6992","display_name":"Humboldt-Universit\u00e4t zu Berlin","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I76198965","ror":"https://ror.org/05qpz1x62","display_name":"Friedrich Schiller University Jena","country_code":"DE","type":"education","lineage":["https://openalex.org/I76198965"]},{"id":"https://openalex.org/I7877124","ror":"https://ror.org/001w7jn25","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","count":2,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":1,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","count":1,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","value":2.13e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","value":8.9e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","value":7.5e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","value":3.8e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","value":2.8e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","score":0.7953739166259766},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.588436484336853},{"id":"121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","score":0.3339557647705078}],"counts_by_year":[{"year":1996,"works_count":2,"oa_works_count":0,"cited_by_count":0}],"display_name_alternatives":["M. Borner"],"block_key":"m borner","works_api_url":"https://api.openalex.org/works?filter=author.id:A5034725804","updated_date":"2026-11-04T11:47:51","created_date":"2016-06-24T00:00:00"}